Prasugrel + Clopidogrel
Phase 2Completed 1 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Acute Coronary Syndrome
Conditions
Acute Coronary Syndrome
Trial Timeline
Mar 1, 2007 → Oct 1, 2007
NCT ID
NCT00385944About Prasugrel + Clopidogrel
Prasugrel + Clopidogrel is a phase 2 stage product being developed by Daiichi Sankyo for Acute Coronary Syndrome. The current trial status is completed. This product is registered under clinical trial identifier NCT00385944. Target conditions include Acute Coronary Syndrome.
What happened to similar drugs?
20 of 20 similar drugs in Acute Coronary Syndrome were approved
Approved (20) Terminated (4) Active (0)
✅Modification of Prasugrel based on a biological assay + prasugrel / clopidogrelDaiichi SankyoApproved
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (10)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01327534 | Phase 3 | Completed |
| NCT01260584 | Approved | Completed |
| NCT01107912 | Phase 1 | Completed |
| NCT01107925 | Phase 1 | Completed |
| NCT01014624 | Approved | Completed |
| NCT00910299 | Phase 2 | Terminated |
| NCT00830960 | Phase 3 | Completed |
| NCT00642174 | Phase 2 | Completed |
| NCT00385944 | Phase 2 | Completed |
| NCT00097591 | Phase 3 | Completed |
Competing Products
20 competing products in Acute Coronary Syndrome